557 related articles for article (PubMed ID: 20406460)
1. Neurocognitive impairment among HIV-positive individuals in Botswana: a pilot study.
Lawler K; Mosepele M; Ratcliffe S; Seloilwe E; Steele K; Nthobatsang R; Steenhoff A
J Int AIDS Soc; 2010 Apr; 13():15. PubMed ID: 20406460
[TBL] [Abstract][Full Text] [Related]
2. Neurobehavioral effects in HIV-positive individuals receiving highly active antiretroviral therapy (HAART) in Gaborone, Botswana.
Lawler K; Jeremiah K; Mosepele M; Ratcliffe SJ; Cherry C; Seloilwe E; Steenhoff AP
PLoS One; 2011 Feb; 6(2):e17233. PubMed ID: 21365002
[TBL] [Abstract][Full Text] [Related]
3. Neurocognitive Impairment in a Chronically Well-Suppressed HIV-Infected Population: The Dutch TREVI Cohort Study.
van den Dries LWJ; Wagener MN; Jiskoot LC; Visser M; Robertson KR; Adriani KS; van Gorp ECM
AIDS Patient Care STDS; 2017 Aug; 31(8):329-334. PubMed ID: 28753395
[TBL] [Abstract][Full Text] [Related]
4. Neurocognitive Disorders in HIV-positive Patients.
Padole PS; Padhiyar RN; Yadav DS; Chavan SA
J Assoc Physicians India; 2023 Jun; 71(6):11-12. PubMed ID: 37355842
[TBL] [Abstract][Full Text] [Related]
5. Psycho-behavioral factors associated with neurocognitive performance among people living with HIV on antiretroviral therapy in Accra, Ghana.
Asiedu N; Kretchy I; Asampong E
Afr Health Sci; 2020 Jun; 20(2):487-596. PubMed ID: 33163015
[TBL] [Abstract][Full Text] [Related]
6. Good neurocognitive performance measured by the international HIV dementia scale in early HIV-1 infection.
Lopardo GD; Bissio E; Iannella Mdel C; Crespo AD; Garone DB; Cassetti LI
J Acquir Immune Defic Syndr; 2009 Dec; 52(4):488-92. PubMed ID: 19654553
[TBL] [Abstract][Full Text] [Related]
7. Cognitive screening in treatment-naïve HIV-infected individuals in Hong Kong - a single center study.
Chan FCC; Chan P; Chan I; Chan A; Tang THC; Lam W; Fong WC; Lee MP; Li P; Chan GHF
BMC Infect Dis; 2019 Feb; 19(1):156. PubMed ID: 30760220
[TBL] [Abstract][Full Text] [Related]
8. Interaction Effects between HIV and Aging on Selective Neurocognitive Impairment.
Ding Y; Lin H; Shen W; Wu Q; Gao M; He N
J Neuroimmune Pharmacol; 2017 Dec; 12(4):661-669. PubMed ID: 28470583
[TBL] [Abstract][Full Text] [Related]
9. Neuropsychological Assessment of 412 HIV-Infected Individuals in São Paulo, Brazil.
Gascón MRP; Vidal JE; Mazzaro YM; Smid J; Marcusso RMN; Capitão CG; Coutinho EM; Benute GRG; De Lucia MCS; de Oliveira ACP
AIDS Patient Care STDS; 2018 Jan; 32(1):1-8. PubMed ID: 29323557
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for HIV-associated neurocognitive disorders (HAND) in sub-Saharan Africa: the case of Yaoundé-Cameroon.
Njamnshi AK; Bissek AC; Ongolo-Zogo P; Tabah EN; Lekoubou AZ; Yepnjio FN; Fonsah JY; Kuate CT; Angwafor SA; Dema F; Njamnshi DM; Kouanfack C; Djientcheu Vde P; Muna WF; Kanmogne GD
J Neurol Sci; 2009 Oct; 285(1-2):149-53. PubMed ID: 19631349
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of neurocognitive disorders and depression in a Brazilian HIV population.
Troncoso FT; Conterno Lde O
Rev Soc Bras Med Trop; 2015; 48(4):390-8. PubMed ID: 26312927
[TBL] [Abstract][Full Text] [Related]
12. Positive and sustained effects of highly active antiretroviral therapy on HIV-1-associated neurocognitive impairment.
Tozzi V; Balestra P; Galgani S; Narciso P; Ferri F; Sebastiani G; D'Amato C; Affricano C; Pigorini F; Pau FM; De Felici A; Benedetto A
AIDS; 1999 Oct; 13(14):1889-97. PubMed ID: 10513647
[TBL] [Abstract][Full Text] [Related]
13. Neurologic manifestations of human immunodeficiency virus-2: dementia, myelopathy, and neuropathy in West Africa.
Choi Y; Townend J; Vincent T; Zaidi I; Sarge-Njie R; Jaye A; Clifford DB
J Neurovirol; 2011 Apr; 17(2):166-75. PubMed ID: 21424866
[TBL] [Abstract][Full Text] [Related]
14. Multicenter European Prevalence Study of Neurocognitive Impairment and Associated Factors in HIV Positive Patients.
Haddow LJ; Laverick R; Daskalopoulou M; McDonnell J; Lampe FC; Gilson R; Speakman A; Antinori A; Balestra P; Bruun T; Gerstoft J; Nielsen L; Vassilenko A; Collins S; Rodger AJ;
AIDS Behav; 2018 May; 22(5):1573-1583. PubMed ID: 28144792
[TBL] [Abstract][Full Text] [Related]
15. Cognitive impairment and antiretroviral treatment in a Peruvian population of patients with human immunodeficiency virus.
Guevara-Silva EA
Neurologia; 2014 May; 29(4):224-9. PubMed ID: 23972623
[TBL] [Abstract][Full Text] [Related]
16. HIV associated neurocognitive disorders (HAND) in Malawian adults and effect on adherence to combination anti-retroviral therapy: a cross sectional study.
Kelly CM; van Oosterhout JJ; Ngwalo C; Stewart RC; Benjamin L; Robertson KR; Khoo S; Allain TJ; Solomon T
PLoS One; 2014; 9(6):e98962. PubMed ID: 24915530
[TBL] [Abstract][Full Text] [Related]
17. Antiretroviral therapy improves cognitive impairment in HIV+ individuals in sub-Saharan Africa.
Sacktor N; Nakasujja N; Skolasky R; Robertson K; Wong M; Musisi S; Ronald A; Katabira E
Neurology; 2006 Jul; 67(2):311-4. PubMed ID: 16864825
[TBL] [Abstract][Full Text] [Related]
18. Limitations of the International HIV Dementia Scale in the current era.
Milanini B; Paul R; Bahemana E; Adamu Y; Kiweewa F; Langat R; Owuoth J; Allen E; Polyak C; Ake J; Valcour V;
AIDS; 2018 Nov; 32(17):2477-2483. PubMed ID: 30134293
[TBL] [Abstract][Full Text] [Related]
19. Neurocognitive screening tools in HIV/AIDS: comparative performance among patients exposed to antiretroviral therapy.
Skinner S; Adewale AJ; DeBlock L; Gill MJ; Power C
HIV Med; 2009 Apr; 10(4):246-52. PubMed ID: 19187172
[TBL] [Abstract][Full Text] [Related]
20. Depression symptoms and cognitive function among individuals with advanced HIV infection initiating HAART in Uganda.
Nakasujja N; Skolasky RL; Musisi S; Allebeck P; Robertson K; Ronald A; Katabira E; Clifford DB; Sacktor N
BMC Psychiatry; 2010 Jun; 10():44. PubMed ID: 20537129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
